Profilo
Kristin Stephens is currently the Chief Development Officer at Syros Pharmaceuticals, Inc. She previously worked as the Vice President-Global Clinical Operations at Millennium Pharmaceuticals, Inc. and as a Vice President at Takeda Pharmaceuticals U.S.A., Inc. She completed her undergraduate degree at Hobart & William Smith Colleges.
Posizioni attive di Kristin Stephens
| Società | Posizione | Inizio |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2018 |
Precedenti posizioni note di Kristin Stephens
| Società | Posizione | Fine |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
Formazione di Kristin Stephens
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Hobart & William Smith Colleges
Hobart & William Smith Colleges Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
















